Moritz F. Eissmann
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 5%
- RNA modifications and cancer
- RNA Research and Splicing
- Circular RNAs in diseases
Papers in
-
- RNA Research and Splicing 5
- RNA modifications and cancer 4
- Oncology 9
- Cytokine Signaling Pathways and Interactions 4
- Cancer Cells and Metastasis 3
- Co-authors
- Sven Diederichs (4 shared papers)Tony Gutschner (4 shared papers)Martin Zörnig (5 shared papers)Monika Hämmerle (3 shared papers)Matthias Groß (3 shared papers)Jeff Hsu (2 shared papers)Alexey S. Revenko (2 shared papers)David L. Spector (2 shared papers)
- Journals
- Cancer Research (4 papers)Cancer Immunology Research (3 papers)Nature Communications (2 papers)eLife (2 papers)genesis (2 papers)
- Partner nations
- AustraliaGermanyUnited States
In The Last Decade
Moritz F. Eissmann
25 papers receiving 2.2k citations
Moritz F. Eissmann's Hit Papers
Peers
Comparison fields: 5 of 86
- Cancer Research 1.4k
- Molecular Biology 1.5k
- Immunology 279
- Oncology 223
- Endocrinology 33
Countries citing papers authored by Moritz F. Eissmann
This map shows the geographic impact of Moritz F. Eissmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moritz F. Eissmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moritz F. Eissmann more than expected).
Fields of papers citing papers by Moritz F. Eissmann
This network shows the impact of papers produced by Moritz F. Eissmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moritz F. Eissmann. The network helps show where Moritz F. Eissmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Moritz F. Eissmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Noncoding RNA MALAT1 Is a Critical Regulator of the Metastasis Phenotype of Lung Cancer Cells Hit paper breakdown → | 2012 | 1323 |
| 2 | 2012 | 331 | |
| 3 | 2019 | 162 | |
| 4 | 2006 | 77 | |
| 5 | 2014 | 54 | |
| 6 | 2016 | 35 | |
| 7 | 2018 | 34 | |
| 8 | 2022 | 30 | |
| 9 | 2021 | 29 | |
| 10 | 2020 | 26 | |
| 11 | 2020 | 24 | |
| 12 | 2023 | 21 | |
| 13 | 2013 | 17 | |
| 14 | 2012 | 15 | |
| 15 | 2015 | 14 | |
| 16 | 2021 | 11 | |
| 17 | 2017 | 9 | |
| 18 | 2016 | 8 | |
| 19 | 2024 | 7 | |
| 20 | 2024 | 4 |
About Moritz F. Eissmann
Moritz F. Eissmann is a scholar working on Molecular Biology, Oncology, Immunology, Surgery and Cancer Research, having authored 27 papers that have together received 2.2k indexed citations. Recurring topics across this work include IL-33, ST2, and ILC Pathways (5 papers), RNA Research and Splicing (5 papers), Cancer-related molecular mechanisms research (5 papers), Immune Cell Function and Interaction (4 papers), Cytokine Signaling Pathways and Interactions (4 papers), RNA modifications and cancer (4 papers), Helicobacter pylori-related gastroenterology studies (3 papers) and Cancer Cells and Metastasis (3 papers). The work is most often cited by research in Cancer Research (1.4k citations), Molecular Biology (1.5k citations), Immunology (279 citations), Oncology (223 citations) and Endocrinology (33 citations). Moritz F. Eissmann has collaborated with scholars based in Australia, Germany and United States. Frequent co-authors include Sven Diederichs, Tony Gutschner, Martin Zörnig, Monika Hämmerle, Matthias Groß, Jeff Hsu, Alexey S. Revenko, David L. Spector, Gayatri Arun and Gene Hung. Their work appears in journals such as Cancer Research, Cancer Immunology Research, Nature Communications, eLife and genesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.